Imagine you are a research analyst evaluating the distribution network of a mid-sized life insurer. As you dissect the ‘Other Income’ and ‘Commission Expenses’ in their annual report, you come across a note regarding their reliance on third-party distribution channels. You notice that they have engaged with a specific corporate agent that also represents three other insurance providers. As a professional, you must instantly understand whether this arrangement is regulatory-compliant or if it flags a potential oversight in the insurer’s business model.
In the Indian insurance regulatory landscape, the distinction between individual agents and corporate agents is pivotal for managing distribution risk. An individual agent is permitted to represent only one life insurer, one general insurer, and one health insurer at any given time. This restriction is designed to ensure that the individual agent remains focused on the products of specific companies, thereby reducing the risk of ‘mis-selling’ through conflicting product pushes. It serves to simplify the agent’s accountability and aligns their professional allegiance with a defined set of underwriting guidelines.
Conversely, a corporate agent—which can be an entity like a bank, a retail chain, or a company—operates under a more flexible but structured framework. Currently, the IRDAI allows a corporate agent to tie up with up to three insurers in each of the life, general, and health insurance categories. This ‘open architecture’ approach is intended to provide consumers with a wider selection of products at a single point of service.
For your research, this means you must evaluate the insurer’s ability to compete for shelf space within these corporate partnerships, as they are no longer guaranteed a monopoly on that entity’s customer base.
Consider a scenario where a large bank acts as a corporate agent. By partnering with three different life insurers, the bank can offer its customers a comparison of products ranging from low-cost term plans to complex wealth-oriented ULIPs. For the analyst, this shift changes how you value the insurer’s distribution growth; you are no longer looking for exclusive distribution contracts, but rather the insurer’s competitive edge in product design, commission structures, and service quality relative to the other two partners sharing the same corporate platform.
Nuance
Check Your Understanding
An individual insurance agent currently represents one life insurance company. They wish to diversify their portfolio by representing two additional life insurers. Under current IRDAI regulations, which of the following is true?
A corporate agent aims to expand its health insurance portfolio. What is the maximum number of health insurance partnerships this entity can maintain?
This is a companion read for Section 1.8 — Regulations pertaining to Insurance from PASS Investment Adviser (Level 2) by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.